John Brancaccio
Chairman chez HEPION PHARMACEUTICALS, INC.
Fortune : 25 722 $ au 31/03/2024
Postes actifs de John Brancaccio
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Chairman | 20/02/2024 | - |
| Director/Board Member | 15/05/2013 | 20/02/2024 | |
| Independent Dir/Board Member | 15/05/2013 | 20/02/2024 | |
| ACTAVIA LIFE SCIENCES, INC. | Director/Board Member | 01/08/2016 | - |
| Independent Dir/Board Member | 01/08/2016 | - | |
| OKYO PHARMA LIMITED | Director/Board Member | 10/06/2020 | - |
| Independent Dir/Board Member | 10/06/2020 | - | |
| ACCUSTEM SCIENCES, INC. | Director/Board Member | 01/03/2021 | - |
| Independent Dir/Board Member | 01/03/2021 | - | |
| TIZIANA LIFE SCIENCES LTD | Director/Board Member | 01/07/2020 | - |
| Independent Dir/Board Member | 01/07/2020 | - | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Director/Board Member | 24/09/2005 | - |
Historique de carrière de John Brancaccio
Anciens postes connus de John Brancaccio
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARDIFF ONCOLOGY, INC. | Director/Board Member | 01/12/2005 | 09/06/2022 |
| Independent Dir/Board Member | 01/12/2005 | 09/06/2022 | |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Director/Board Member | 01/04/2004 | 01/05/2020 |
| SYNERGY PHARMACEUTICALS INC | Director/Board Member | 01/07/2008 | 01/04/2019 |
| Independent Dir/Board Member | 01/07/2008 | 01/04/2019 | |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de John Brancaccio
| Seton Hall University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 13 |
| Hong Kong | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 12 |
| Independent Dir/Board Member | 8 |
| Director of Finance/CFO | 4 |
Sectorielle
| Health Technology | 11 |
| Consumer Services | 3 |
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| ELINE ENTERTAINMEN | Consumer Services |
| OKYO PHARMA LIMITED | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Entreprise privées | 10 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
Active With Me, Inc.
 Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Active With Me, Inc. provides online resources that seamlessly offer travelers unique, highly relevant and user-friendly information on activity-based travel. Its listings will be provided for product and service providers of interest to the activity-based traveler. The company was founded on December 6, 2012 and is headquartered in Sarnia, Canada. | Commercial Services |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Health Technology |
Orchestra Medical Ventures LLC
 Orchestra Medical Ventures LLC Investment ManagersFinance Orchestra Medical Ventures LLC (Orchestra Medical Ventures) is a venture capital firm founded in 2001 by Richard P. Geoffrion and Yuval Binur. The firm is headquartered in New Hope, Pennsylvania. | Finance |
FermaVir Pharmaceuticals LLC
FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Health Technology |
Accelerated Technologies, Inc.
 Accelerated Technologies, Inc. Medical DistributorsDistribution Services Accelerated Technologies, Inc. creates and accelerates cardiovascular medical devices. The company was founded by Martin B. Leon and Yuval Binur and is headquartered in Hackensack, NJ. | Distribution Services |
| AccuStem Sciences, Inc. | |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- John Brancaccio
- Expérience
